Charles Schwab’s ContraFect Corporation CFRX Stock Holding History

Charles Schwab’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-246	Closed	-$61K	–	3610
2022 Q2	$61K	Hold	246	–	–	﹤0.01%	3366
2022 Q1	$72K	Hold	246	–	–	﹤0.01%	3474
2021 Q4	$52K	Hold	246	–	–	﹤0.01%	3513
2021 Q3	$80K	Hold	246	–	–	﹤0.01%	3404
2021 Q2	$87K	Sell	246 -491	-67%	-$161K	﹤0.01%	3307
2021 Q1	$283K	Buy	737 +54	+8%	+$23.3K	﹤0.01%	3261
2020 Q4	$276K	Hold	683	–	–	﹤0.01%	3192
2020 Q3	$289K	Buy	683 +271	+66%	+$123K	﹤0.01%	3040
2020 Q2	$211K	Buy	+412	New	+$202K	﹤0.01%	3160
2020 Q1	–	Sell	-49	Closed	-$25K	–	3264
2019 Q4	$25K	Hold	49	–	–	﹤0.01%	3156
2019 Q3	$15K	Hold	49	–	–	﹤0.01%	3165
2019 Q2	$20K	Hold	49	–	–	﹤0.01%	3202
2019 Q1	$16K	Hold	49	–	–	﹤0.01%	3189
2018 Q4	$60K	Buy	+49	New	+$77.7K	﹤0.01%	3123

Other funds holding CFRX

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

AAS

Avantax Advisory Services Dallas, Texas $18.2B AUM 15.06% 1-Year Est. Return

Charles Schwab's CFRX Position: Q3 2022 in Review

Charles Schwab sold out of ContraFect Corporation (CFRX) in Q3 2022, closing a stake of 246 shares — an estimated $61K sold.

Charles Schwab first reported a position in CFRX in Q4 2018 and held it in 14 quarters. The position peaked at $289K in Q3 2020. 46 funds tracked by Wall St. Rank hold CFRX as of Q3 2022.

Charles Schwab reported no remaining ContraFect Corporation position as of Q3 2022 after selling out during the quarter.
Charles Schwab sold 246 ContraFect Corporation shares in Q3 2022, an estimated $61K.
Charles Schwab first reported a position in ContraFect Corporation in Q4 2018 and held it in 14 quarters.
Charles Schwab's ContraFect Corporation position peaked at $289K in Q3 2020.
46 funds tracked by Wall St. Rank held ContraFect Corporation as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.